Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
228.89B
Market cap228.89B
Price-Earnings ratio
26.05
Price-Earnings ratio26.05
Dividend yield
2.34%
Dividend yield2.34%
Average volume
2.76M
Average volume2.76M
High today
$426.07
High today$426.07
Low today
$420.66
Low today$420.66
Open price
$421.64
Open price$421.64
Volume
656.21K
Volume656.21K
52 Week high
$426.07
52 Week high$426.07
52 Week low
$269.77
52 Week low$269.77

Stock Snapshot

The current Amgen(AMGN) stock price is $423.38, with a market capitalization of 228.89B. The stock trades at a price-to-earnings (P/E) ratio of 26.05 and offers a dividend yield of 2.34%.

On 2026-08-18, Amgen(AMGN) stock traded between a low of $420.66 and a high of $426.07. Shares are currently priced at $423.38, which is +0.6% above the low and -0.6% below the high.

The Amgen(AMGN)'s current trading volume is 656.21K, compared to an average daily volume of 2.76M.

During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $426.07 at its peak.

During the past year, Amgen(AMGN) stock moved between $269.77 at its lowest and $426.07 at its peak.

AMGN News

TipRanks 4h
Amgen price target raised to $400 from $350 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on Amgen (AMGN) to $400 from $350 and keeps a Neutral rating on the shares. The revised estimates better captur...

MarketWatch 19h
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
TipRanks 23h
Amgen’s Evolocumab Formulation Study Signals Steady Support for Its Cholesterol Franchise

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

Analyst ratings

49%

of 35 ratings
Buy
37.1%
Hold
48.6%
Sell
14.3%

More AMGN News

Simply Wall St 2d
Should Income Investors Look At Amgen Inc. Before Its Ex-Dividend?

Readers hoping to buy Amgen Inc. ( ) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date occ...

Should Income Investors Look At Amgen Inc. Before Its Ex-Dividend?
TipRanks 3d
Schwab US Dividend Equity ETF Sees Strong Inflows, Stable Performance

Schwab US Dividend Equity ETF ( $SCHD ) has risen by 0.97% in the past week. It has experienced a 5-day net inflow of $858.07 million. This is due, in part, to...

TipRanks 3d
Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.

Insiders have been trading these 5 stocks: ((AMGN)), ((CEG)), ((FSLY)), ((KEEL)) and ((BX)). Here is a breakdown of their recent trades and their value. SVP BD...

Nasdaq 4d
GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)

Key Points Amgen is developing a highly differentiated GLP-1 product. Regeneron has a pair of promising GLP-1 candidates in the pipeline. Both biotechs are p...

GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)
TipRanks 4d
Amgen Targets Autoimmune Hepatitis With New Inebilizumab Trial

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

Nasdaq 4d
Dow Movers: AMGN, HONIV

In early trading on Friday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7...

Dow Movers: AMGN, HONIV
Simply Wall St 4d
Amgen Stock Looks Below Fair Value As Caution Lingers

Amgen stock has delivered a strong 116.3% return over the past 5 years, while the current checks show a mixed picture and the Discounted Cash Flow (DCF) intrins...

Amgen Stock Looks Below Fair Value As Caution Lingers

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.